Frieder Bauss
12Patents
6h-index
15Co-inventors
63Inventor score
Filing activity: Nov 25, 1991 → Jan 9, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5538957A | Phosphonosuccinic acid derivatives, processes for their preparation and medicaments containing these compounds | Chemistry; Metallurgy | 26 | Expired |
| US7410957B2 | Method of treatment using bisphosphonic acid | Human Necessities | 22 | Expired |
| US9180185B2 | Combination therapy of anti-HER3 antibodies | Chemistry; Metallurgy | 10 | Active |
| US7718634B2 | Method of treatment using bisphosphonic acid | Human Necessities | 9 | Active |
| US7192938B2 | Method of treatment using bisphosphonic acid | Human Necessities | 9 | Expired |
| US6680307B1 | Use of ibandronate for promoting osseointegration of endoprostheses | Human Necessities | 7 | Expired |
| US5206253A | Disphosphonic acid derivatives, processes for their production and pharmaceutical preparations containing these compounds | Chemistry; Metallurgy | 6 | Expired |
| US5683994A | Phosphosuccinic acid derivatives, processes for the production thereof and pharmaceutical agents containing these compounds | Chemistry; Metallurgy | 2 | Expired |
| US5543561A | Acyclic amidine group-containing diphosphonic acid derivatives, processes for their preparation and medicaments containing these compounds | Human Necessities | 1 | Expired |
| US5698541A | 2,4-diphosphonoglutaric acid derivatives, processes for their production and pharmaceutical agents containing these compounds | Chemistry; Metallurgy | 0 | Expired |
| US6476008B1 | Use of diphosphonic acids or the physiologically acceptable salts or esters thereof in the preventive treatment of after-effects resulting from enlargement or replacement of the bladder | Human Necessities | 0 | Expired |
| US5627170A | Phosphonic acid compound containing heterocyclic substituents, pharmaceutical composition contains same and a method of treating calcium metabolism disturbance | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.